IAM Magazine issue 04

February/March 2004

The making of a licensing legend

Stanford University’s Office of Technology Licensing has a string of headline success stories to its name – from DNA gene-splicing to Cisco, Yahoo! and Sun Microsystems. Since it was founded in 1970, it has also received US$594 million in cumulative gross royalties. No wonder it is considered a world leader in technology transfer. By Nigel Page


Accurate IP valuation in multiple environments

The IP rights belonging to a well-managed, buoyant company will be worth a lot more than those owned by a business on the verge of bankruptcy. The key to a successful IP valuation therefore is to understand the reasons why it is being done in the first place. By Weston Anson and Daryl Martin

Getting it right the Australian way

The results of a recent in-depth survey of Australian companies’ attitudes to intellectual property management have lessons that go far beyond the country. Nowhere is this more so than in the work being done by organisations that have identified IP rights as key drivers for growth. By Timothy Devinney and Adam Liberman

Opportunity knocks for IP owners in China

For many years China has had a terrible reputation among intellectual property owners. Undoubtedly huge problems do remain but these have not deterred a number of IP-rich foreign companies from doing business in the country, And, if they know what they are doing, the potential upside is enormous. By Alan Adcock

Patent time bombs

In certain circumstances, patent applications can be more valuable to an organisation than patents themselves. However, this does not happen by accident – specific strategies have to be put in place. By Craig Opperman

The challenges of 2004

During 2003 there were major developments in the world’s intellectual asset management landscape. Some more welcome than others. And it is clear that the pace of change shows no signs of letting up. Senior figures from industry, the law and representative organisations explain what they saw as the key issues of the last 12 months and what we need to be looking out for in 2004. By Joff Wild


Another one bites the dust

For 120 years, New York’s Pennie & Edmonds was a specialist IP law firm with a pedigree second to none. That did not stop it going out of business at the end of 2003. Now, with America’s general practice firms showing little sign of scaling back their interest in intellectual property, the pressure is on the surviving specialist firms to keep them at bay

Biotech companies must face up to generic rivals

In the next few years it is likely that generic biotechnology products will begin to hit the European and American markets. Biotech companies will try to slow the process down but they cannot stop it. Which should be good news for them and patients


Patent predictions - facts or fictions

According to some theories we might be at the beginning of the next golden age of innovation. But then again, we might be wrong

Prickly profits

Last month’s IP Investor focused on the double standard applied to persons who deploy intangibles like patents for profit, as opposed to investors who deal in hard assets. The net-net: real estate moguls are capitalists; aggressive exploiters of IP are anti-competitive. The following are insights from prominent patent owners, managers and advisers about the IP double standard and what can be done to mitigate it

US antitrust enforcers focus on IP

Not only has the FTC recently pursued an aggressive antitrust enforcement agenda in matters implicating IP rights, but it has recently taken the rather extraordinary step of trying to effect changes to the existing substantive laws and procedural rules in the patent field


Register for more free content

  • Read more IAM blogs and articles
  • Receive the editor's weekly review by email
Register now  
Issue 90